Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$737M |
| 2 |
Invesco S&P 500 Revenue ETF
RWL
|
+$669M |
| 3 |
Bank of America
BAC
|
+$513M |
| 4 |
Amazon
AMZN
|
+$510M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$482M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco S&P 500 Pure Value ETF
RPV
|
+$491M |
| 2 |
Trade Desk
TTD
|
+$466M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$373M |
| 4 |
Eli Lilly
LLY
|
+$367M |
| 5 |
Williams-Sonoma
WSM
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.41% |
| 2 | Financials | 13.31% |
| 3 | Industrials | 11.28% |
| 4 | Healthcare | 10.55% |
| 5 | Consumer Discretionary | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3601
Alto Neuroscience
ANRO
$1.06B
| $67K | ﹤0.01% |
+31,031
| New | +$111K |
|
|
HSHP
3602
Himalaya Shipping
HSHP
$697M
| $66.4K | ﹤0.01% |
12,119
-619
| -5% | -$3.24K |
|
3603
Invivyd
IVVD
$162M
| $66K | ﹤0.01% |
108,999
+71,485
| +191% | +$64.1K |
|
3604
Precigen
PGEN
$1.96B
| $65.3K | ﹤0.01% |
43,806
-3,501
| -7% | -$5.51K |
|
|
NNDM
3605
Nano Dimension
NNDM
$316M
| $63.4K | ﹤0.01% |
+39,846
| New | +$90.2K |
|
|
AKYA
3606
DELISTED
Akoya BioSciences
AKYA
| $62.7K | ﹤0.01% |
+45,141
| New | +$98.8K |
|
|
NSLR
3607
Neostellar Capital Corp
NSLR
$263M
| $62.3K | ﹤0.01% |
+12,526
| New | +$72.9K |
|
3608
Vivid Seats
SEAT
$84.4M
| $62.2K | ﹤0.01% |
1,052
-94
| -8% | -$7.57K |
|
3609
Sutro Biopharma
STRO
$387M
| $59.9K | ﹤0.01% |
9,214
+5,339
| +138% | +$84.1K |
|
3610
Cardiff Oncology
CRDF
$63.2M
| $59.8K | ﹤0.01% |
19,046
+161
| +0.9% | +$637 |
|
|
VXRT
3611
DELISTED
Vaxart
VXRT
| $59.6K | ﹤0.01% |
146,366
+70,568
| +93% | +$45.3K |
|
3612
Candel Therapeutics
CADL
$710M
| $58.8K | ﹤0.01% |
+10,413
| New | +$85.1K |
|
3613
HF Foods Group
HFFG
$80.7M
| $57.4K | ﹤0.01% |
11,719
-630
| -5% | -$1.72K |
|
3614
AirSculpt Technologies
AIRS
$315M
| $56.4K | ﹤0.01% |
+24,169
| New | +$109K |
|
3615
Caribou Biosciences
CRBU
$147M
| $53.8K | ﹤0.01% |
58,974
-6,721
| -10% | -$8.73K |
|
3616
AbCellera Biologics
ABCL
$1.67B
| $53.8K | ﹤0.01% |
24,146
+12,893
| +115% | +$37K |
|
|
IAUX
3617
i-80 Gold Corp
IAUX
$1.11B
| $53.7K | ﹤0.01% |
92,274
-878
| -0.9% | -$568 |
|
3618
Rimini Street
RMNI
$466M
| $52.4K | ﹤0.01% |
15,049
-491
| -3% | -$1.59K |
|
3619
Cadiz
CDZI
$249M
| $52.1K | ﹤0.01% |
17,794
-634
| -3% | -$2.79K |
|
|
RGLS
3620
DELISTED
Regulus Therapeutics
RGLS
| $51.6K | ﹤0.01% |
29,460
-788
| -3% | -$1.04K |
|
3621
Humacyte
HUMA
$169M
| $51.4K | ﹤0.01% |
30,145
-782
| -3% | -$2.94K |
|
3622
Riskified
RSKD
$727M
| $50.8K | ﹤0.01% |
+10,994
| New | +$55.4K |
|
|
AUTL
3623
Autolus Therapeutics
AUTL
$383M
| $50.7K | ﹤0.01% |
32,738
+11,381
| +53% | +$23.1K |
|
|
MODV
3624
DELISTED
ModivCare
MODV
| $50.1K | ﹤0.01% |
38,104
-9,520
| -20% | -$46.1K |
|
3625
Personalis
PSNL
$1.27B
| $48.7K | ﹤0.01% |
13,869
-321
| -2% | -$1.52K |
|
Similar funds
Invesco's Q1 2025 Portfolio in Review
As of Q1 2025, Invesco held 3,856 positions worth $528B, down 2.4% from $541B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Invesco's Q1 2025 filing shows 117 new, 1,793 increased, 1,749 reduced and 89 closed positions. Its largest new stake was Invesco Managed Futures Strategy ETF: 4,184,000 shares worth $206M. The largest sale was Invesco S&P 500 Pure Value ETF, an estimated $491M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
- Invesco's largest Q1 2025 buy was Invesco Managed Futures Strategy ETF: 4,184,000 shares worth $206M.
- Invesco added most to Tesla in Q1 2025, an estimated $737M increase.
- Invesco's biggest Q1 2025 reduction was Invesco S&P 500 Pure Value ETF, cutting an estimated $491M.
- Invesco fully exited ENLINK MIDSTREAM, LLC in Q1 2025, selling an estimated $281M.
- Invesco's ten largest holdings make up 17% of its $528B portfolio in Q1 2025.
- Invesco opened 117 new positions and closed 89 in Q1 2025.
- Invesco's portfolio value fell 2.4% quarter-over-quarter to $528B.
Based on Invesco's 13F filing for Q1 2025, filed 12 May 2025.